Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (Mpro) using molecular docking and deep learning methods
Alomgir Hossain, Md. Ekhtiar Rahman, Md Siddiqur Rahman, et al.
Computers in Biology and Medicine (2023) Vol. 157, pp. 106785-106785
Open Access | Times Cited: 18

Showing 18 citing articles:

Investigation of phytochemicals isolated from selected Saudi medicinal plants as natural inhibitors of SARS CoV-2 main protease: In vitro, molecular docking and simulation analysis
Yousef Alharbi, Wael M. Abdel‐Mageed, Omer A. Basudan, et al.
Saudi Pharmaceutical Journal (2024) Vol. 32, Iss. 5, pp. 102023-102023
Open Access | Times Cited: 4
Recent advances in chemometric modelling of inhibitors against SARS-CoV-2
Qianqian Wang, Xinyi Lu, Runqing Jia, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24209-e24209
Open Access | Times Cited: 2
Characterization of Plant-Derived Natural Inhibitors of Dipeptidyl Peptidase-4 as Potential Antidiabetic Agents: A Computational Study
Alomgir Hossain, Md. Ekhtiar Rahman, Md Omar Faruqe, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 483-483
Open Access | Times Cited: 2
Marine natural compounds as potential CBP bromodomain inhibitors for treating cancer: an in-silico approach using molecular docking, ADMET, molecular dynamics simulations and MM-PBSA binding free energy calculations
Md. Liakot Ali, Fabiha Noushin, Eva Azme, et al.
In Silico Pharmacology (2024) Vol. 12, Iss. 2
Closed Access | Times Cited: 2
Utilizing in silico Methods in New Drug Design
Olivia Pérez‐Valera, Yuri Córdoba-Campo, Rafael Torres‐Martínez, et al.
Recent advances in biotechnology (2024), pp. 20-51
Closed Access | Times Cited: 1
Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CLPro and PLPro) by Molecular Docking and Dynamic Simulation Studies
Quaiser Saquib, Ahmed H. Bakheit, Sarfaraz Ahmed, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 998-998
Open Access | Times Cited: 1
Machine Learning Integrated Drug Discovery Process Investigating Possible Drug Molecule against COVID-19 Disease: A Review
Sanjay Shrinivas Nagar, R.S. Upendra, R Karthik
(2024), pp. 1661-1666
Closed Access | Times Cited: 1
Phytochemicals: Promising Inhibitors of Human Rhinovirus Type 14 3C Protease as a Strategy to Fight the Common Cold
Nefeli Theodora Tsilimingkra, Christos Papaneophytou
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 15, pp. 1343-1358
Closed Access | Times Cited: 1
Conventional Understanding of SARS‐CoV‐2 Mpro and Common Strategies for Developing Its Inhibitors
Kun Zhou, Daquan Chen
ChemBioChem (2023) Vol. 24, Iss. 22
Closed Access | Times Cited: 2
Cracking a cancer code DNA methylation in epigenetic modification: an in-silico approach on efficacy assessment of Sri Lanka-oriented nutraceuticals
R. Dushanan, Samantha Weerasinghe, D. P. Dissanayake, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-21
Closed Access
Understanding Plant Secondary Metabolism Using Bioinformatics Tools
Dola Mukherjee, Ashutosh Mukherjee
(2024), pp. 459-488
Closed Access
Breaking the Chain: Protease Inhibitors as Game Changers in Respiratory Viruses Management
Christos Papaneophytou
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8105-8105
Open Access
Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS‐CoV‐2 main protease
Maryelle A. G. de Carvalho, Gabriella B. Souza, Tiago Tizziani, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 11
Closed Access
Computational Investigations to Identify Potent Natural Flavonoid Inhibitors of the Nonstructural Protein (NSP) 16/10 Complex Against Coronavirus
Silambarasan Tamil Selvan, Gurupavan Kumar Ganta
Cureus (2024)
Open Access
Novel chiral phthalimides: Antimicrobial evaluation and docking study against Acinetobacter baumannii's OmpA protein
Rimsha Abid, Momin Khan, Nayyer Siddique, et al.
Computers in Biology and Medicine (2024) Vol. 182, pp. 109099-109099
Closed Access
Nature's pharmacy: A deep learning approach for identification of medicinal plants
Nanaji Uppe
i-manager’s Journal on Future Engineering and Technology (2024) Vol. 19, Iss. 4, pp. 18-18
Closed Access
Emerging Paradigms in Natural Products-Based Drug Discovery
S. J. Soumya, Kesavan R. Arya, Chandran S. Abhinand, et al.
(2024), pp. 231-246
Closed Access
Covalent Inhibitors from Saudi Medicinal Plants Target RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2
Ahmed H. Bakheit, Quaiser Saquib, Sarfaraz Ahmed, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2175-2175
Open Access | Times Cited: 1
Page 1

Scroll to top